Lung Cancer

Click here for RSS
top border
top border
Featured Program
http://www.onclive.com/_media/_image/Photo-Combo_shaw.jpg
Targeted therapies in non-small cell lung cancer include EGFR inhibitors and ALK inhibitors. Gregory J. Riely, MD, Alice Shaw, MD, PhD, Mark Socinski, MD, provide insight into the latest research in advanced non-small cell lung cancer, including next-generation agents and novel treatment approaches. View Now

The ever increasing landscape of therapeutic choices available for lung adenocarcinoma adds complexity when determining the best approach for treatment. This OncLive Peer Exchange moderated by Mark Socinski, MD, focuses on what to consider when choosing a treatment strategy for an individual patient. The panelists are Benjamin Levy, MD; John Longshore, PhD; Gregory Riely, MD, PhD; Thomas Stinchcombe, MD; and Jared Weiss, MD. View Now
Immunotherapy and Oncology

Anti-Angiogenic Therapy in Lung and GI Cancers

Anti-Angiogenic Therapy in Lung and GI Cancers
Mark Socinski, MD, moderates this OncLive Peer Exchange panel discussion on modern use of anti-angiogenic therapy. The experts in gastrointestinal and lung cancers include Johanna C. Bendell, MD; Edward Garon, MD; Roy Herbst, MD; Yelena Y. Janjigian, MD; and Manish Shah, MD.
View Now
Vincent T. DeVita Jr MD
In The Death of Cancer, written by Vincent T. DeVita Jr, MD, a pioneering oncologist reveals, after 50 years on the front lines of medicine, why the war on cancer is winnable, and how to get there.
Publication Bottom Border
Border Publication